Combination Treatment Targeting mTOR and MAPK Pathways Has Synergistic Activity in Multiple Myeloma

SIMPLE SUMMARY: Multiple myeloma (MM) is characterized by the clonal accumulation of abnormal plasma cells in the bone marrow. Although current treatments have improved the survival rates of patients with MM, MM remains incurable for most patients due to refractory disease and relapse. Thus, new the...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Kaiyan, Jin, Ling, Karolová, Jana, Vorwerk, Jan, Hailfinger, Stephan, Opalka, Bertram, Zapukhlyak, Myroslav, Lenz, Georg, Khandanpour, Cyrus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136620/
https://www.ncbi.nlm.nih.gov/pubmed/37190302
http://dx.doi.org/10.3390/cancers15082373

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136620/
https://www.ncbi.nlm.nih.gov/pubmed/37190302
http://dx.doi.org/10.3390/cancers15082373

Ejemplares similares